Nextech Invest AG
- SEC CIK
- 0001911010
- Latest filing
- Feb 14, 2025
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 1, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 14
- 0 vs. Q1 2022
- Portfolio value
- $296.5M
- −$53.8M (−15.4%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RVMDRevolution Medicines, Inc. | COM | 3,939,529 | $76.8M | 25.9% | 00.0% | Unchanged | History |
| EQRXEQRx, Inc. | COM | 13,104,424 | $61.5M | 20.7% | 00.0% | Unchanged | History |
| KNTEKinnate Biopharma Inc. | COM | 3,008,243 | $37.9M | 12.8% | 00.0% | Unchanged | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 1,385,807 | $19.7M | 6.7% | 00.0% | Unchanged | History |
| TYRATyra Biosciences, Inc. | COM | 2,518,582 | $18.0M | 6.1% | 00.0% | Unchanged | History |
| MRTXMirati Therapeutics, Inc. | COM | 263,914 | $17.7M | 6.0% | +90,614+52.3% | Added | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,221,145 | $15.7M | 5.3% | 00.0% | Unchanged | History |
| ARVNArvinas, Inc. | COM | 287,251 | $12.1M | 4.1% | 00.0% | Unchanged | History |
| BPMCBlueprint Medicines Corp | COM | 188,228 | $9.51M | 3.2% | 00.0% | Unchanged | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 1,910,029 | $8.10M | 2.7% | 00.0% | Unchanged | History |
| RLAYRelay Therapeutics, Inc. | COM | 475,485 | $7.96M | 2.7% | 00.0% | Unchanged | History |
| KRONKronos Bio, Inc. | COM | 1,451,537 | $5.28M | 1.8% | 00.0% | Unchanged | History |
| THRXTheseus Pharmaceuticals, Inc. | COM | 611,310 | $3.38M | 1.1% | 00.0% | Unchanged | History |
| CCCCC4 Therapeutics, Inc. | COM STK | 375,857 | $2.83M | 1.0% | 00.0% | Unchanged | History |